Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ionis Pharmaceutical (IONS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ionis Pharmaceutical 2855 GAZELLE COURT CARLSBAD CA 92010 USA

P: 760-931-9200

Description:

Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.

Key Statistics

Overview:

Market Capitalization, $K 10,919,602
Shares Outstanding, K 138,398
Annual Sales, $ 599,670 K
Annual Net Income, $ 273,740 K
Last Quarter Sales, $ 192,110 K
Last Quarter Net Income, $ 320,080 K
60-Month Beta 2.40
% of Insider Shareholders 2.44%
% of Institutional Shareholders 84.31%
Float, K 135,021
% Float 97.56%

Growth:

1-Year Return 55.38%
3-Year Return 89.57%
5-Year Return 98.74%
5-Year Revenue Growth 307.14%
5-Year Earnings Growth 638.18%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 2.21 on 02/27/19
Next Earnings Date 05/03/19
Earnings Per Share ttm 2.26
EPS Growth vs. Prev Qtr 8,166.67%
EPS Growth vs. Prev Year 12,000.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

IONS Ratios

Ratio
Price/Earnings ttm 34.55
Price/Earnings forward -127.63
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 41.89
Return-on-Assets (Before Tax) 16.00
Net Margin % N/A
Debt/Equity 0.74
Price/Sales 18.58
Price/Cash Flow 25.16
Price/Book 9.33
Book Value/Share 8.63
Interest Coverage -0.70
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar